Stage
Name the environment, specimen, organism or site actually tested.
Reading method · 02
Label simulation, material coupon, bench, in-vitro, animal, field prototype, regulated study and operational use without compressing them into one maturity claim.
FUURAA thesis
Engineering map
Each layer states the boundary to establish and the evidence needed for the next decision.
Name the environment, specimen, organism or site actually tested.
Limit each conclusion to outcomes directly observed at that stage.
State what evidence is still required before translation or deployment.
Verification questions
Each question needs an object, conditions, denominator, threshold and accountable decision owner.
Was the result simulated, in vitro, in vivo or operational?
Were safety and effectiveness measured or only feasibility?
Which configuration and supervision produced the result?
What translation barrier remains most uncertain?
Evidence to preserve
A conclusion alone loses reviewability; raw records, configuration and exclusions matter too.
Stage-labelled evidence ledger
Claim-to-observation trace
Unresolved translation-risk register
Scope boundary
Animal, in-vitro or field-prototype success must not be described as human, clinical or general operational readiness.
This is an engineering reading and decision framework; it does not replace application-specific risk assessment, conformity work, procurement acceptance or professional advice.
Sources and evidence status
Source dates and review status remain visible; external sources open in a new tab.
Integrates a soluble capsule, magnetic navigation, X-ray visibility, catheter release and drug delivery, with testing in vascular models and large animals.
Reports magnetic coordination, three-dimensional motion, aggregation and shape-adaptive attachment, including ultrasound-guided control in in-vitro models.
Reports an amphibious turtle robot with multimodal terrain adaptation and a modular worm-like soft pipe robot tested across defined loads, diameters, slopes and gaps.